FI944907A - Uusi antineoplastinen sytokiini - Google Patents

Uusi antineoplastinen sytokiini Download PDF

Info

Publication number
FI944907A
FI944907A FI944907A FI944907A FI944907A FI 944907 A FI944907 A FI 944907A FI 944907 A FI944907 A FI 944907A FI 944907 A FI944907 A FI 944907A FI 944907 A FI944907 A FI 944907A
Authority
FI
Finland
Prior art keywords
oncoinhibin
human
new antineoplastic
cytokine
provides
Prior art date
Application number
FI944907A
Other languages
English (en)
Swedish (sv)
Other versions
FI944907A0 (fi
FI112081B (fi
Inventor
Bharat Aggarwal
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of FI944907A0 publication Critical patent/FI944907A0/fi
Publication of FI944907A publication Critical patent/FI944907A/fi
Application granted granted Critical
Publication of FI112081B publication Critical patent/FI112081B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI944907A 1992-04-24 1994-10-19 Menetelmä uuden antineoplastisen sytokiinin valmistamiseksi ja puhdistamiseksi FI112081B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/874,308 US5241051A (en) 1992-04-24 1992-04-24 Oncoinhibin
US87430892 1992-04-24
PCT/US1993/003828 WO1993022346A1 (en) 1992-04-24 1993-04-23 A novel anti-neoplastic cytokine
US9303828 1993-04-23

Publications (3)

Publication Number Publication Date
FI944907A0 FI944907A0 (fi) 1994-10-19
FI944907A true FI944907A (fi) 1994-10-19
FI112081B FI112081B (fi) 2003-10-31

Family

ID=25363462

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944907A FI112081B (fi) 1992-04-24 1994-10-19 Menetelmä uuden antineoplastisen sytokiinin valmistamiseksi ja puhdistamiseksi

Country Status (18)

Country Link
US (1) US5241051A (fi)
EP (1) EP0637319B1 (fi)
JP (1) JP3434511B2 (fi)
KR (1) KR950701347A (fi)
CN (1) CN1068335C (fi)
AT (1) ATE209500T1 (fi)
AU (1) AU671637B2 (fi)
CA (1) CA2118498C (fi)
DE (1) DE69331231T2 (fi)
FI (1) FI112081B (fi)
IL (1) IL105473A (fi)
NO (1) NO313099B1 (fi)
NZ (1) NZ252429A (fi)
RU (1) RU2139087C1 (fi)
SA (1) SA93140393B1 (fi)
TW (1) TW372873B (fi)
WO (1) WO1993022346A1 (fi)
ZA (1) ZA932830B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993798A (en) * 1992-04-24 1999-11-30 Research Development Foundation Oncoinhibin and methods of pharmaceutical use
WO1997036495A1 (en) * 1996-04-03 1997-10-09 The Rogosin Institute Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
SG10201912642RA (en) * 2012-01-18 2020-02-27 Biosuccess Biotech Co Ltd Compositions and methods of use of phorbol esters
EP3464374A2 (en) 2016-06-06 2019-04-10 City of Hope Baff-r antibodies and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6463395A (en) * 1987-05-04 1989-03-09 Oncogen Oncostatin m and novel composition having antitumor activity
CA2028825A1 (en) * 1989-04-10 1990-10-11 Thomas J. Brown Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m

Also Published As

Publication number Publication date
AU4113593A (en) 1993-11-29
DE69331231T2 (de) 2002-08-22
ZA932830B (en) 1994-11-22
NO313099B1 (no) 2002-08-12
NO943968D0 (no) 1994-10-19
FI944907A0 (fi) 1994-10-19
IL105473A0 (en) 1993-08-18
EP0637319A4 (en) 1997-06-11
NO943968L (no) 1994-10-19
CA2118498A1 (en) 1993-11-11
IL105473A (en) 1998-09-24
KR950701347A (ko) 1995-03-23
EP0637319A1 (en) 1995-02-08
US5241051A (en) 1993-08-31
ATE209500T1 (de) 2001-12-15
AU671637B2 (en) 1996-09-05
JPH07506364A (ja) 1995-07-13
CN1068335C (zh) 2001-07-11
RU2139087C1 (ru) 1999-10-10
DE69331231D1 (de) 2002-01-10
FI112081B (fi) 2003-10-31
SA93140393B1 (ar) 2006-05-23
JP3434511B2 (ja) 2003-08-11
NZ252429A (en) 1996-06-25
TW372873B (en) 1999-11-01
EP0637319B1 (en) 2001-11-28
WO1993022346A1 (en) 1993-11-11
RU94045922A (ru) 1997-05-10
CA2118498C (en) 2005-06-21
CN1083389A (zh) 1994-03-09

Similar Documents

Publication Publication Date Title
IT8920207A0 (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
DE69004731D1 (de) Hilfsmittel enthaltende verdünnbare Formulierungen von Nachlaufherbiziden.
IT1196484B (it) Vettore ad espressione e secrezione in lieviti,utile per la preparazione di proteine eterologhe
IT8722481A0 (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse.
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
IT8522668A0 (it) Procedimento per la preparazione di (2,2)-paraciclofani alogenati e miscele di (2,2)-paraciclofani alogenati ottenuti.
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
FI944907A (fi) Uusi antineoplastinen sytokiini
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ES2071004T3 (es) Nuevos peptidos, su uso para inhibir la maduracion de linfocitos t y la actividad de macrofagos, y procesos para su preparacion.
IT1216560B (it) Procedimento per la preparazione di bis(2,2,6,6_tetrametil_4_piperidil)ammina.
IT1230068B (it) Procedimento per la preparazione di n sulfoniluree.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ES2152315T3 (es) Xamoneline tartrato.
NO904800D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamater.
NO872671D0 (no) 4-benzyloksy-3-pyrrolin-2-on-1-yl-acetamid, fremstilling og anvendelse derav.
ES2129053T3 (es) Nuevos derivados de fosfolipidos.
ITMI911604A1 (it) Procedimento per la preparazione della n- (2, 6-diclorofenil) -n-fenil-n-(cloroacetil)-ammina.
CS326486A2 (en) Method of 17-alpha-phenyl-17-beta-hydroxy-18-methyl-4,15-oestradien-3-on' production
ZA893310B (en) Novel strobilurine derivatives,their preparation and their use
ES2042572T3 (es) Procedimiento e intermedios para la obtencion de n-(s-3-alquilheptanoil)-d-gamma-glutamil-glicil-d-alanina.
ES1010441Y (es) Mesa para la practica de lucha de brazos.
IT8822478A0 (it) Procedimento per la preparazione della n (2,6 diclorofenil) n feniln (cloroacetil) ammina.
ES542554A0 (es) Un procedimiento para preparar (6,11-dihidro-11-oxodibenznb,e)oxepinil)pentanoles
IT8919405A0 (it) Procedimento per la preparazione di pentaclorotiofenolo.

Legal Events

Date Code Title Description
MA Patent expired